Astellas Venture Management invests $1m in DecImmune Therapeutics.
Category: Deals
Repsol greases AlgaEnergy deal
Spain-based oil group Repsol acquires a fifth of biofuels company AlgaEnergy.
STV screens for Mirriad shot
veteran broadcaster Peter Bazalgette joins Mirriad as chairman as company closes round with STV Group backing.
T-Venture caught in Innovid
Deutsche Telekom joins Innovid’s series A round consortium.
Fujitsu strikes Tensilica investment
Japan’s Fujitsu joins compatriot NTT Docomo as strategic investor in chip company Tensilica.
Verizon finds way with Geodelic
US-based location software company Geodelic closed its $7m series B round between April and end-June with strategic investment from Verizon Ventures.
Argos still shopping to fill funding round
Argos Therapeutics, a biotechnology company previously known as Merix Bioscience, three-quarters of way through $6m funding round.
LinkedIn finds its ChoiceVendor
SAP and McGraw-Hill-backed business networking group LinkedIn acquires ChoiceVendor.
MerchantCircle keeps TimeBridge appointment
Steamboat Ventures-backed MerchantCircle acquires TimeBridge.
Aster Data gains $30m in C round
Undisclosed strategic backs storage company Aster Data’s C round.
Roche builds defences with CytomX
Third Rock Ventures and Roche Venture Fund invest $30m in CytomX Therapeutics
Betfair gambles again on UK flotation
Softbank-backed Betfair tries again for UK listing.
Brammo revs engine for B round
US electrical retailer Best Buy’s corporate venturing division, oil and gas developer Alpine and venture capital firm Chrysalix initial backers of Brammo’s series B round.
Six Apart talks its way into forming Say Media
Intel Capital-backed Six Apart merges with VideoEgg to form Say Media.